Summary
Overview
Work History
Education
Skills
Language
References
Personal Data
Timeline
Generic
Tamer Attia Zahran

Tamer Attia Zahran

Salwa

Summary

Dynamic and driven pharmaceutical professional with over 15 years of experience improving marketing strategies, delivering medical data, and achieving remarkable sales results across diverse therapeutic areas. Successfully managed teams throughout career in the pharmaceutical industry. Seeking a challenging position within a dynamic team at a progressive and reputable organization to leverage competences, cultivate skills, and drive career development. Professional brand management expert with a strong track record in developing and executing strategic marketing initiatives, driving brand growth, and enhancing market presence through innovative campaigns and data-driven decisions. Collaborative team player focused on achieving results and adapting to changing market needs. Skilled in market analysis, consumer insights, and cross-functional team leadership.

Overview

11
11
years of professional experience

Work History

National Sales Manager

Abbott Kuwait
08.2024 - Current
  • Team Leadership: Managed a team of 3 sales managers with a spam of control of 21 sales representative with a turnover of $25 million.
  • Strategic Brand Articulation: Translated Abbott brand strategies into actionable regional plans.
  • Performance Evaluation: Evaluated monthly sales performance in reference to projected budgets.
  • Field Force Optimization: Appraised field force metrics by implementing proper Sales Force Effectiveness (SFE) strategies. This optimization enhanced team productivity.
  • Talent Development: Led and supported a dynamic team members. Mentorship and coaching fostered individual and collective growth.

Sales Manager, Upper Gulf: Kuwait/Qatar

Amgen
06.2023 - 08.2024
  • Team Leadership: Managed a team of 9 sales product specialists with a turnover of $25 million.
  • Strategic Brand Articulation: Translated Amgen brand strategies into actionable regional plans.
  • Performance Evaluation: Evaluated monthly sales performance in reference to projected budgets.
  • Field Force Optimization: Appraised field force metrics by implementing proper Sales Force Effectiveness (SFE) strategies. This optimization enhanced team productivity.
  • Talent Development: Led and supported a dynamic team of nine members. Mentorship and coaching fostered individual and collective growth.
  • Workplace Recognition: Achieved the title of “Best Place to Work in Kuwait Qatar” for 2023. Ranked as the second-best place to work in Kuwait’s pharmaceutical field, reflecting your dedication to employee satisfaction.
  • Achievements:
  • Cardiovascular:
  • Market Share Growth: Successfully captured a 10% market share from the main competitor in Kuwait. Reach 85% market share.
  • Repatha Enlistment: Skillfully enlisted Repatha in primary healthcare (PHC).
  • Consumption Growth: Achieved a 30% increase in Repatha consumption from 23 to 24.
  • Sales Growth: Demonstrated impressive sales performance with a 40% growth from 23 to 24.
  • Immunology:
  • The consumption of biosimilars has doubled, showing significant growth in this market segment.
  • Achieved a 3% market share compared to the branded drug Adalimumab. This is a noteworthy accomplishment.
  • We effectively relaunched Apremilas by positioning it correctly for the target patient profile. This strategic move contributed to its success.

Product Manager, Gulf

Amgen
06.2022 - 06.2023
  • Strategic Formulation: Crafted a robust marketing strategy for Amgen’s nephrology legacy. This involved understanding market dynamics, competitive forces, and customer needs.
  • Rebranding Success: Skillfully rebranded Aranesp in response to a dynamic competitive landscape and new product launches. Your adaptability and strategic thinking were instrumental in this achievement.
  • Effective Collaboration: Collaborated with intercontinental and regional Product Managers to create a contemporary and vivid nephrology brand plan. This cross-functional teamwork ensured alignment and consistency.
  • Event Relaunch: Successfully relaunched the Amgen Nephro Summit event for KSA-Gulf. Your efforts contributed to fostering knowledge exchange and networking within the nephrology community.

Sales Manager, Upper Gulf: Kuwait/Qatar/Bahrain

Amgen
02.2018 - 06.2023
  • Strategic Brand Articulation: Translated Amgen brand strategies into actionable regional plans.
  • Performance Evaluation and Optimization: Evaluated monthly sales performance progress in reference to projected budgets. Appraised field force metrics through the implementation of proper Sales Force Effectiveness (SFE) strategies.
  • Team Leadership and Talent Development: Led and supported a dynamic team of six members. Your mentorship and coaching fostered individual and collective growth. Coached the team through mentored field visits to optimize their performance.
  • Collaboration Across Functions: Worked closely with cross-functional teams in access, marketing, and medical. Your collaboration streamlined workflows with MOH, regulatory bodies, and CMS.
  • Achievements:
  • Nephrology:
  • Aranesp Market Share: Achieved an impressive 93% market share for Aranesp in the Upper Gulf.
  • Parsabiv Launch Success: Skillfully launched and enlisted Parsabiv, achieving a remarkable penetration rate of ≥45%.
  • Mimpara Protection: Successfully cannibalized Mimpara while safeguarding its position against generic threats. This strategic move ensured continued success for Mimpara.
  • Oncology:
  • Xgeva lead bone targeted field with an impressive 95% market share.
  • Aranesp Oncology Success Realized a ≥50% market share for Aranesp in oncology compared to blood transfusion. Your effective market positioning contributed to this achievement.
  • Vectibex Leadership in Colorectal Cancer Led the field of colorectal cancer with a remarkable 55% market share for Vectibex.
  • KRAS Testing Paradigm: Successfully established the KRAS testing paradigm in the Upper Gulf. advocacy for testing awareness impacted patient care.
  • Educating Healthcare Professionals (oncologists and pathologists) on the importance of KRAS testing in MCRC patients. Highlighted the role of target anti-EGFR therapies like Vectibex in colorectal cancer management.
  • Launched Sotorasib and raised awareness about the KRAS G12C mutation, which affects 13% of NSCLC patients. Educated oncologists on Sotorasib as the first KRAS G12C inhibitor in NSCLC treatment.
  • Value of Upfront Testing: Emphasized the value of upfront testing in NSCLC due to disease nature and biopsy challenges. Early detection is critical for better outcomes.
  • Hematology:
  • Nplate leadership in Immune Thrombocytopenia: Successfully conquered the Immune Thrombocytopenia market with 60% market share for Nplate.
  • Kyprolis Consumption Growth in Multiple Myeloma: Augmented yearly consumption of Kyprolis in Multiple Myeloma by an impressive 40% growth.
  • Blincyto Revolution in Acute Lymphoblastic Leukemia: Revolutionized the treatment of Acute Lymphoblastic Leukemia by achieving a 100% market share for Blincyto.
  • MRD Awareness and Testing Guidelines: Established the concept of MRD (Minimal Residual Disease) as an important prognostic factor in ALL. Collaborating with hematology and pathology, you raised awareness on MRD testing guidelines in Kuwait and Qatar.
  • Blincyto Immunotherapy Launch: Successfully launched Blincyto as the only novel immunotherapy targeting patients with MRD-positive CD19 B cell ALL.

Regional Medical Manger (Upper Gulf)

Amgen
01.2014 - 02.2018
  • Educational Partnership: Established Amgen as an educational partner across various therapeutic areas. Efforts contributed to knowledge dissemination and collaboration.
  • ZERBINI Trial Inauguration: Managed the inauguration of the ZERBINI trial, the first of its kind in the Middle East. Leadership in clinical research was groundbreaking.
  • Scientific Initiatives: Supported the initiation of scientific projects in UAE, Oman, and the Levant region. Commitment to advancing scientific knowledge is commendable.
  • Achievements:
  • Cardiology: Enlisted Repatha in MOH within 3 months from FDA approval and optimized the launch through successful advisory board and international speaker tours with Prof. Lansberg and Prof. John Chapman
  • Nephrology: Established the milestones for DOPPS Clinical trial, the longest running trial in the gulf region and collaborated with Kuwait Nephrology Association (KNA) to build their website
  • Prolia: Refurbished the treatment of osteoporosis through establishing an essential Course endorsed by Kuwait Osteoporosis Society (KOPS) and introduced Prolia in the Local osteoporosis guidelines as cornerstone in first line treatment

Education

Mini MBA -

01.2013

Bachelor’s degree - pharmacy & Biotechnology

German University in Cairo (GUC)
01.2008

Skills

  • Adaptable and proficient working under pressure
  • Skilled in developing business relations and building rapport
  • Committed and dedicated
  • Hard worker and team player
  • Excellent command of Microsoft Office applications in precisely comprehension of budget and sales sheet in addition to IMS data

Language

Arabic: Mother tongue
English: Fluent in written and spoken
German: Fair

References

References available upon request

Personal Data

  • Marital status: Married
  • Nationality: Egyptian
  • Date of Birth: 17th March 1984

Timeline

National Sales Manager

Abbott Kuwait
08.2024 - Current

Sales Manager, Upper Gulf: Kuwait/Qatar

Amgen
06.2023 - 08.2024

Product Manager, Gulf

Amgen
06.2022 - 06.2023

Sales Manager, Upper Gulf: Kuwait/Qatar/Bahrain

Amgen
02.2018 - 06.2023

Regional Medical Manger (Upper Gulf)

Amgen
01.2014 - 02.2018

Bachelor’s degree - pharmacy & Biotechnology

German University in Cairo (GUC)

Mini MBA -

Tamer Attia Zahran